top of page
The Professional Network for Healthcare Experts
GE HealthCare agrees $945m acquisition of SOFIE Biosciences to expand US radiopharma network
GE HealthCare has agreed to acquire SOFIE Biosciences for $945 million, expanding its US PET radiopharmaceutical manufacturing and distribution network.
nuaxia
Oct 62 min read
FDA approves Telix Pixclara as first FET-PET imaging drug for glioma
The FDA has approved Telix's Pixclara as the first FET-PET imaging agent in the United States for evaluating glioma, providing a new tool to help distinguish tumour progression from treatment-related changes.
nuaxia
Sep 142 min read
bottom of page